Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Creo Medical ( (GB:CREO) ) has shared an announcement.
Creo Medical Group plc has announced the award of shares under its HMRC approved Share Incentive Plan (SIP), aimed at UK-based employees and directors. This initiative involves the acquisition of 248,132 ordinary shares at £0.191 per share, with the company issuing an additional 324,340 new shares to fulfill SIP obligations. This move strengthens stakeholders’ engagement by offering equity participation and is expected to enhance the company’s market presence in the medical device industry.
More about Creo Medical
Creo Medical Group plc is a medical device company specializing in minimally invasive electrosurgical devices aimed at improving outcomes for pre-cancer and cancer patients. The company focuses on endoscopy solutions using its advanced CROMA powered by Kamaptive technology, which enhances surgical precision and adaptability, providing a safer and more efficient alternative to traditional surgical methods.
YTD Price Performance: -5.13%
Average Trading Volume: 887,428
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £76.25M
See more data about CREO stock on TipRanks’ Stock Analysis page.
